Press Release Archives

Press Release

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical…

CertaraMarch 3, 2026

Press Release

Certara to Participate in Upcoming Investor Conferences

RADNOR, PA – February 27, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraFebruary 27, 2026

Press Release

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…

CertaraFebruary 26, 2026

Press Release

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026

Radnor, Pa. — January 29, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in…

CertaraJanuary 29, 2026

Press Release

Certara Appoints Jon Resnick as Chief Executive Officer

Resnick brings decades of leadership experience in health sciences, business operations, strategy, innovation and commercial…

CertaraDecember 11, 2025

Press Release

Certara Reports Third Quarter 2025 Financial Results

RADNOR, PA— November 6, 2025-- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development,…

CertaraNovember 6, 2025

Press Release

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara has released TFL studio, a module in its cloud-native PK/PD software, Phoenix Cloud, to…

CertaraNovember 4, 2025

Press Release

Certara to Participate in Upcoming Investor Conferences

Certara announced that Company management will participate in upcoming investor conferences. Learn more in the…

CertaraOctober 31, 2025

Press Release

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Discover how Certara IQ accelerates drug development through scalable, QSP Modeling with AI-Powered Biosimulation.

CertaraOctober 30, 2025

Press Release

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Certara celebrates its 200 published papers and 11 scientists ranked in the top 2% of…

CertaraOctober 20, 2025

Press Release

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Certara to Participate in Upcoming Investor Conferences

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

Certara to Report Fourth Quarter and Full Year 2025 Financial Results on February 26th, 2026

Certara Appoints Jon Resnick as Chief Executive Officer

Certara Reports Third Quarter 2025 Financial Results

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara to Participate in Upcoming Investor Conferences

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Newsletter sign up

Quick links

Solutions

Contact